Toyoko Oguri

1.3k citations
85 papers · 626 indexed · h-index 15
Topics
Antifungal resistance and susceptibility (20 papers)Antimicrobial Resistance in Staphylococcus (16 papers)Antibiotic Use and Resistance (14 papers)
Partner nations
JapanUnited StatesSpain

In The Last Decade

Toyoko Oguri

79 papers receiving 593 citations

Peers

Toyoko Oguri
Comparison fields: 5 of 75
  • Infectious Diseases 349
  • Epidemiology 229
  • Molecular Biology 143
  • Clinical Biochemistry 135
  • Molecular Medicine 115
Replace R L Kaplan with:
R L Kaplan United States
Genoveva Yagüe Spain
E Huczko United States
Kazue Ueno Japan
M S Barrett United States
Carlos del Ojo Elías United Kingdom
Michael J. Rybak United States
Sharon A. Crawford United States
H. Drugeon France
P.‐M. Rath Germany
Toyoko Oguri relative to R L Kaplan United States R L Kaplan's profile →
Citations per field
00.5×3.8×
R L Kaplan · 1×
Citations per year

Countries citing papers authored by Toyoko Oguri

Since Specialization
Citations

This map shows the geographic impact of Toyoko Oguri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toyoko Oguri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toyoko Oguri more than expected).

Fields of papers citing papers by Toyoko Oguri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toyoko Oguri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toyoko Oguri. The network helps show where Toyoko Oguri may publish in the future.

Co-authorship network of co-authors of Toyoko Oguri

This figure shows the co-authorship network connecting the top 25 collaborators of Toyoko Oguri. A scholar is included among the top collaborators of Toyoko Oguri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toyoko Oguri. Toyoko Oguri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 1
3 4
4 26
5 18
6 24
7 3
8 14
9
In vitro antimicrobial activity of oral β-lactam antibiotics against Streptococcus pneumoniae from clinical specimens
3
10 3
11 15
12
Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987)
3
13 6
14 0
15
Antibacterial activity of ceftazidime against various bacteria recently isolated from clinical materials compared with that of other cephems
1
16 0
17
Serotypes and drug-susceptibility of streptococcus pneumoniae isolated from clinical specimens
2
18 1
19 1
20
[Clinical and bacteriological study on Flavobacterium meningosepticum (author's transl)].
4

About Toyoko Oguri

Toyoko Oguri is a scholar working on Applied Microbiology and Biotechnology, Microbiology and Molecular Medicine, having authored 85 papers that have together received 626 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (20 papers), Antimicrobial Resistance in Staphylococcus (16 papers) and Antibiotic Use and Resistance (14 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (49 citations), Molecular Medicine (115 citations) and Clinical Biochemistry (135 citations). Toyoko Oguri has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include J Igari, Hideo IKEMOTO, Takeshi Mori, Longzhu Cui, Keiichi Hiramatsu, Kazuo Oshimi, Makiko Matsumura, Kaoru Shimada, Satoshi Hori and Hajime Goto. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026